- List
- By Topic
- On Map
- Search Details

2502 AND formulation
Need help? See RSS Feeds
Choose a feed type:

2502 AND formulation (5 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03708133 | Recruiting | Study to Assess Bioequivalence of a New Nifurtimox Oral Tablet Formulation |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
24 | All | 18 Years to 45 Years (Adult) | NCT03708133 | 19500 | December 5, 2018 | March 29, 2019 | June 21, 2019 | October 17, 2018 | January 24, 2019 |
|
|||
2 | NCT02625974 | Active, not recruiting | Prospective Study of a Pediatric Nifurtimox Formulation for Chagas' Disease |
|
|
Interventional |
Phase 3 |
|
Industry |
|
|
330 | All | up to 17 Years (Child) | NCT02625974 | 16027 | CHICO | January 27, 2016 | July 25, 2018 | August 9, 2021 | December 9, 2015 | January 4, 2019 |
|
||
3 | NCT03350295 | Completed | Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
48 | All | 18 Years to 45 Years (Adult) | NCT03350295 | 16007 | June 14, 2018 | September 18, 2018 | December 14, 2018 | November 22, 2017 | January 8, 2019 |
|
|||
4 | NCT01927224 | Completed | Study to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients |
|
|
Interventional |
Phase 1 |
|
Industry |
|
|
37 | All | 18 Years to 45 Years (Adult) | NCT01927224 | 16004 | November 2013 | May 2014 | September 2014 | August 22, 2013 | October 16, 2015 |
|
|||
5 | NCT03712761 | Active, not recruiting | Supplementation of a Leucine-Enriched Dairy Protein Blend |
|
|
Observational |
|
Other |
|
|
8 | All | 65 Years and older (Older Adult) | NCT03712761 | 2502 | March 28, 2018 | May 1, 2019 | May 1, 2019 | October 19, 2018 | January 8, 2019 |
|
† Study has passed its completion date and status has not been verified in more than two years.